{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:23Z","timestamp":1791918983141,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Necrotizing enterocolitis (NEC) is a serious complication predominantly affecting very low birth weight neonates, characterized by high mortality and long-term morbidity. Neonatal diabetes mellitus (NDM) is a rare condition with diverse etiologies, including genetic predisposition and autoimmune mechanisms. To our knowledge, NEC and NDM have never been previously reported together.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We report the clinical case of a late preterm infant whose mother had received an immune checkpoint inhibitor treatment (pembrolizumab) for metastatic gastric cancer during pregnancy. The infant suffered from severe and recurrent necrotizing enterocolitis (NEC), neonatal diabetes mellitus (NDM) and exocrine pancreatic insufficiency that required a multidisciplinary approach. Prenatal exposure to pembrolizumab might explain the co-occurrence of the three diseases and the complex and unusual medical history of the child, even if the possibility that these events were independent of each other cannot be totally ruled out.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This case suggests the potential association between antenatal pembrolizumab exposure and severe neonatal comorbidities. Furthermore, it highlights the challenge of managing concurrent NEC, NDM and exocrine pancreatic insufficiency in early infancy, emphasizing the need for multidisciplinary care and long-term follow-up to address complex clinical and developmental outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13052-025-02021-8","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T17:11:54Z","timestamp":1752858714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prenatal pembrolizumab exposure as the potential link among recurrent necrotizing enterocolitis, neonatal diabetes mellitus and exocrine pancreatic insufficiency: a case report"],"prefix":"10.1186","volume":"51","author":[{"given":"Pasquale","family":"Castaldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Altimari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Capretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Maltoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scozzarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Corvaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Aceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"2021_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12887-020-02231-5","volume":"20","author":"A Alsaied","year":"2020","unstructured":"Alsaied A, Islam N, Thalib L. Global incidence of necrotizing enterocolitis: a systematic review and Meta-analysis. BMC Pediatr. 2020;20(1):344.","journal-title":"BMC Pediatr"},{"key":"2021_CR2","doi-asserted-by":"crossref","unstructured":"Wang Y, Hang C, Hu J, Li C, Zhan C, Pan J et al. Role of gut-brain axis in neurodevelopmental impairment of necrotizing enterocolitis. Front Neurosci. 2023 Jan 19 [cited 2024 Jul 3];17. Available from: https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/10.3389\/fnins.2023.1059552\/full","DOI":"10.3389\/fnins.2023.1059552"},{"issue":"1","key":"2021_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clp.2017.10.006","volume":"45","author":"MB Lemelman","year":"2018","unstructured":"Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus: an update on diagnosis and management. Clin Perinatol. 2018;45(1):41\u201359.","journal-title":"Clin Perinatol"},{"issue":"3","key":"2021_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MPG.0b013e3181da213e","volume":"51","author":"E Bertino","year":"2010","unstructured":"Bertino E, Spada E, Occhi L, Coscia A, Giuliani F, Gagliardi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51(3):353\u201361.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"01","key":"2021_CR5","doi-asserted-by":"publisher","first-page":"013","DOI":"10.1055\/s-0032-1306264","volume":"22","author":"M Thyoka","year":"2012","unstructured":"Thyoka M, Eaton S, Hall N, Drake D, Kiely E, Curry J, et al. Advanced necrotizing Enterocolitis part 2: recurrence of necrotizing Enterocolitis. Eur J Pediatr Surg. 2012;22(01):013\u20136.","journal-title":"Eur J Pediatr Surg"},{"issue":"3","key":"2021_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.47338\/jns.v2.41","volume":"2","author":"O Abbo","year":"2013","unstructured":"Abbo O, Harper L, Michel JL, Ramful D, Breden A, Sauvat F. Necrotizing Enterocolitis in full term neonates: is there always an underlying cause?? J Neonatal Surg. 2013;2(3):29.","journal-title":"J Neonatal Surg"},{"key":"2021_CR7","unstructured":"Flynn JP, Gerriets V. Pembrolizumab. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 2]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546616\/"},{"issue":"12","key":"2021_CR8","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1016\/S1470-2045(21)00525-8","volume":"22","author":"JSW Borgers","year":"2021","unstructured":"Borgers JSW, Heimovaara JH, Cardonick E, Dierickx D, Lambertini M, Haanen JBAG, et al. Immunotherapy for cancer treatment during pregnancy. Lancet Oncol. 2021;22(12):e550\u201361.","journal-title":"Lancet Oncol"},{"issue":"19","key":"2021_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa2308135","volume":"389","author":"MA Baarslag","year":"2023","unstructured":"Baarslag MA, Heimovaara JH, Borgers JSW, Van Aerde KJ, Koenen HJPM, Smeets RL, et al. Severe Immune-Related enteritis after in utero exposure to pembrolizumab. N Engl J Med. 2023;389(19):1790\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"2021_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4093\/dmj.2023.0072","volume":"47","author":"YK Cho","year":"2023","unstructured":"Cho YK, Jung CH. Immune-Checkpoint Inhibitors-Induced type 1 diabetes mellitus: from its molecular mechanisms to clinical practice. Diabetes Metab J. 2023;47(6):757\u201366.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"2021_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/annonc\/mdw626","volume":"28","author":"A Hoadley","year":"2017","unstructured":"Hoadley A, Sandanayake N, Long GV. Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy. Ann Oncol. 2017;28(2):434\u20135.","journal-title":"Ann Oncol"},{"key":"2021_CR12","doi-asserted-by":"publisher","first-page":"612760","DOI":"10.3389\/fped.2021.612760","volume":"9","author":"F Barzaghi","year":"2021","unstructured":"Barzaghi F, Passerini LIPEX, Syndrome. Improved knowledge of immune pathogenesis empowers diagnosis. Front Pediatr. 2021;9:612760.","journal-title":"Front Pediatr"},{"issue":"5","key":"2021_CR13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0016-5085(72)80109-4","volume":"62","author":"AF Hofmann","year":"1972","unstructured":"Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. Gastroenterology. 1972;62(5):918\u201334.","journal-title":"Gastroenterology"},{"issue":"11","key":"2021_CR14","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.3390\/jcm11113102","volume":"11","author":"G Marasco","year":"2022","unstructured":"Marasco G, Cremon C, Barbaro MR, Falangone F, Montanari D, Capuani F, et al. Pathophysiology and clinical management of bile acid diarrhea. J Clin Med. 2022;11(11):3102.","journal-title":"J Clin Med"},{"key":"2021_CR15","doi-asserted-by":"crossref","unstructured":"Achufusi TGO, Sharma A, Zamora EA, Manocha D. Small intestinal bacterial overgrowth: comprehensive review of diagnosis, prevention, and treatment methods. Cureus. 2020;12(6):e8860.","DOI":"10.7759\/cureus.8860"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02021-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02021-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:20:07Z","timestamp":1757254807000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02021-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02021-8","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written and signed consent to publish the information was obtained from the patients\u2019 guardians prior to submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}